Spanish Red Biotech Pipeline

MSD

Pembrolizumab/Lenvatinib

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Subjects with KRASG12C Mutant Advanced Solid Tumors
Phase: 1Phase I in Spain